Guidelines for Managing Gastroesophageal Reflux Disease (GERD)

Diagnosis and Initial Assessment

Warning signs requiring further investigation include bilious vomiting, gastrointestinal bleeding, forceful vomiting, and abdominal tenderness 3
For patients with typical GERD symptoms without alarm features, empiric PPI therapy is appropriate initial management without the need for endoscopy 2
Diagnostic tests should be used to establish a causal relationship between reflux and symptoms, evaluate treatment effectiveness, and exclude other diagnoses 3

Weight loss should be recommended for all overweight or obese patients with GERD as it improves symptoms and pH profiles 1
Elevation of the head of bed (6-8 inches) significantly reduces nighttime symptoms and improves esophageal pH profiles 1
Avoid lying down for 2-3 hours after meals to reduce esophageal acid exposure 1, 2
Limit fat intake to less than 45g per day as part of an antireflux diet 2

PPIs are the most effective first-line pharmacological treatment for patients with GERD, superior to H2-receptor antagonists and antacids 1, 2
Standard PPI therapy should be initiated for 4-8 weeks for typical GERD symptoms 1
PPIs should be taken 30-60 minutes before meals for optimal effect 1
If symptoms persist despite standard PPI therapy, increase to twice-daily PPI dosing 1, 2
Adding H2-receptor antagonists at bedtime can help control nighttime symptoms 1
Consider endoscopy after failed empiric therapy to assess for esophagitis or other pathology 2

For confirmed PPI-refractory GERD, consider surgical options like laparoscopic fundoplication in experienced centers 1
Adding prokinetic therapy to PPI treatment may be considered for patients with persistent symptoms despite optimized PPI therapy 2
Implementing a strict antireflux diet may be beneficial for patients with persistent symptoms 2

More intensive therapy, including twice-daily PPI dosing for 8-12 weeks, may be required for patients with extraesophageal GERD symptoms (chronic cough, laryngitis, asthma) 1, 2
Response rates to PPI therapy are lower for extraesophageal symptoms compared to typical GERD symptoms 2
For infants with GERD, consider a 2-4 week trial of maternal exclusion diet (restricting at least milk and egg) for breastfed infants or extensively hydrolyzed protein formula for formula-fed infants 3, 4, 5
Thickening feedings and smaller, more frequent feedings can help reduce symptoms in infants 3, 4, 5
For children and adolescents, PPIs should only be used for confirmed GERD, not for physiologic GER 1

Fundoplication is the most common surgical intervention for GERD and is associated with significant morbidity 3, 5, 6
Surgery should be reserved for carefully selected patients who have not improved with pharmacologic treatment or who have severe risk of aspiration 5, 6
Before surgery, other etiologies should be carefully considered, and patients should be counseled about realistic expectations 5, 6

Avoid using metoclopramide as monotherapy or adjunctive therapy for GERD due to unfavorable risk-benefit profile (adverse effects include drowsiness, restlessness, and extrapyramidal reactions) 1, 2
Chronic antacid therapy is generally not recommended to treat GERD due to associated risks 3
H2 antagonists can cause tachyphylaxis within six weeks and may increase the risk of liver disease and gynecomastia 3
PPI therapy may be associated with increased risk of community-acquired pneumonia, gastroenteritis, and candidemia 3